Skip to content

Artivion AORT Shares (Diluted)

Discontinued — last reported Q1 '26

Shares (Diluted) at other companies

Abbott logo
AbbottABT
1.7B0.0%
Edwards Lifesciences logo
Edwards LifesciencesEW
580.7M-1.2%
LeMaitre Vascular logo
LeMaitre VascularLMAT
23M+0.6%
Medtronic logo
MedtronicMDT
1.3B-0.1%
ITG
Integer HoldingsITGR
34.4M+1.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
60M-2.1%

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-22.7%
Enterprise value$1.27B-25.5%
P/E91.5×
P/S2.3×-1.2×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's shares (diluted)?
Artivion (AORT) reported shares (diluted) of 49.7M in Q1 2026.
How has Artivion's shares (diluted) changed year-over-year?
Artivion's shares (diluted) increased by 17.8% year-over-year, from 42.2M to 49.7M.
What is the long-term trend for Artivion's shares (diluted)?
Over 4 years (2021 to 2025), Artivion's shares (diluted) has grown at a 3.3% compound annual growth rate (CAGR), from 161.1M to 183.5M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.